Dr Lalchandani Labs Stock Screener | Share Price & Fundamental Analysis
Track Dr Lalchandani Labs share price live with TickJournal's free stock screener.
Analyze Dr Lalchandani Labs share price history trends and compare 52-week high low
levels.
Calculate DLCL stock fair value using fundamental analysis and view live share price charts.
Determine Dr Lalchandani Labs share intrinsic value and compare it with current DLCL share price.
Record your Dr Lalchandani Labs trades in TickJournal's free trading journal and track your portfolio performance.
Dr Lalchandani Labs Market Cap
₹8.25 Cr.
EPS (TTM)
₹0.96
Dividend Yield
-
Debt to Equity
0.39
Dr Lalchandani Labs 52 Week Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹16.00
Total Equity
₹10.00
Dr Lalchandani Labs Share Price History - Stock Screener Chart
Screen DLCL historical share price movements with interactive charts. Analyze price trends and patterns.
Dr Lalchandani Labs Company Profile - Fundamental Screener
Screen Dr Lalchandani Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DLCL shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE871Z01013
Dr Lalchandani Labs Balance Sheet Screener
Screen DLCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 16 | 15 | 18 | 18 | 15 | 12 | 10 | 6 |
| Current Assets | 11 | 10 | 11 | 11 | 9 | 8 | 6 | 4 |
| Fixed Assets | 4 | 4 | 5 | 6 | 5 | 4 | 3 | 2 |
| Liabilities | ||||||||
| Total Liabilities | 16 | 15 | 18 | 18 | 15 | 12 | 10 | 6 |
| Current Liabilities | 0 | 0 | 4 | 3 | 3 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 10 | 10 | 9 | 11 | 10 | 9 | 8 | 3 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Reserves & Surplus | 6 | 5 | 5 | 6 | 5 | 4 | 4 | 0 |
Dr Lalchandani Labs Income Statement Screener - Profit & Revenue Analysis
Screen Dr Lalchandani Labs income statement and profit fundamentals.
Analyze DLCL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr Lalchandani Labs share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 5 | 5 | 5 | 11 | 10 | 6 | 5 | 3 |
| Expenses | 0 | 4 | 5 | 5 | 9 | 8 | 5 | 4 | 2 |
| EBITDA | 0 | 1 | 0 | 0 | 2 | 2 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 21.00% | 4.00% | 2.00% | 21.00% | 23.00% | 21.00% | 23.00% | 22.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | -2 | 1 | 1 | 1 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | -2 | 1 | 1 | 1 | 1 | 0 |
| EPS | 0.00 | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 | 1.09 | 1.23 | 0.89 |
Dr Lalchandani Labs Cash Flow Screener - Liquidity Fundamentals
Screen DLCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 |
| Investing Activities | 0 | 1 | 0 | -2 | -2 | -1 | -2 | -1 |
| Financing Activities | 1 | -2 | 0 | 0 | 2 | 1 | 4 | 2 |
| Net Cash Flow | 1 | -1 | 0 | 1 | 1 | 0 | 1 | 1 |
Dr Lalchandani Labs Shareholding Pattern Screener
See Dr Lalchandani Labs shareholding pattern with promoter, FII, and DII holdings.
Check Dr Lalchandani Labs promoter holding and ownership changes for DLCL on TickJournal.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Mar | 2022-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.32% | 31.15% | 60.78% | 57.18% | 60.78% | 60.78% | 60.78% | 60.78% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.68% | 64.51% | 32.94% | 36.54% | 32.75% | 33.03% | 33.58% | 34.32% |
| Other Holding | 6.00% | 4.34% | 6.28% | 6.28% | 6.46% | 6.18% | 5.63% | 4.89% |
| Shareholder Count | 246 | 206 | 165 | 181 | 162 | 159 | 151 | 157 |
Dr Lalchandani Labs Share Dividend Screener - Share Yield Analysis
Check Dr Lalchandani Labs dividend history with payout and yield data.
View Dr Lalchandani Labs dividend details including ex-dates and amounts for DLCL stock.
Dr Lalchandani Labs Stock Index Membership
See which indices include Dr Lalchandani Labs stock.
Check DLCL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Dr Lalchandani Labs Market Events Screener - Corporate Actions
Get Dr Lalchandani Labs corporate actions including splits, bonuses, and buybacks.
Check Dr Lalchandani Labs stock events that may affect DLCL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -9.35% | ||
| Annual General Meeting | NA | -12.62% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.98% |
| 2025-05-01 | 2025-05-01 | Quarterly Result Announcement | NA | -6.09% |
| 2024-10-14 | 2024-10-14 | Quarterly Result Announcement | NA | 5.18% |
Dr Lalchandani Labs Competitors Screener - Peer Comparison
Screen DLCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,588 | 43.78 | 2,555 | 11.28% | 492 | 32.49 |
| Vijaya Diagnostic Centre | 10,584 | 68.56 | 700 | 23.06% | 144 | 56.57 |
| Metropolis Healthcare | 9,778 | 62.09 | 1,346 | 10.64% | 146 | 39.96 |
| Thyrocare Technologies | 7,200 | 57.36 | 702 | 20.80% | 91 | 50.72 |
| Nephrocare Health Services | 4,770 | 69.25 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,365 | 28.02 | 743 | 16.70% | 78 | 39.66 |
| Suraksha Diagnostic | 1,415 | 45.85 | 256 | 15.11% | 31 | 33.48 |
| One Global Service Provider | 1,273 | 27.75 | 148 | 134.60% | 19 | 64.86 |
| 3B BlackBio DX | 1,256 | 25.22 | 112 | 28.72% | 48 | 64.75 |
| Sastasundar Ventures | 961 | -107.11 | 1,171 | -18.47% | -134 | 45.71 |
Dr Lalchandani Labs Company Announcements - News Screener
Screen DLCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-20 | Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Scheduled On December 22 2025 | View |
| 2026-02-15 | Board Meeting Intimation for Fund Raising | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On December 15 2025 | View |
| 2025-12-09 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-12-02 | Board Meeting Intimation for Considering Of Raising Of Funds Through A Rights Issue And/Or Any Other Permissible Mode | View |
| 2025-11-14 | Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 2025 | View |
| 2025-11-14 | Unaudited Financials Results For The Half Year Ended September 30 2025 | View |
| 2025-11-10 | Board Meeting Intimation for Consider And Approve Financial Statements For The Half Year Ended 30.09.2025 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-06 | Notice Of 08Th Annual General Meeting Of The Company | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Book Closure For The Purpose Of 08Th Annual General Meeting Of The Company | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-05 | Appointment Of M/S Chauhan Pradeep & Associates As Secretarial Auditor Of The Company For The Period Of 5 Years | View |
| 2025-09-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. September 05 2025 | View |